Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection

The Journal of Clinical Investigation
Barbara RehermannFrancis V Chisari

Abstract

It has been suggested that immune selection pressure exerted by the cytotoxic T lymphocyte (CTL) response could be responsible for viral persistence during chronic hepatitis B virus infection. To address this question, in the current study we compared the DNA and amino acid sequences of, and the CTL responses to, multiple HLA-A2-restricted CTL epitopes in the hepatitis B virus in several HLA-A2-positive patients with acute and chronic hepatitis. Our results indicate that the CTL response to these epitopes is barely detectable in the majority of patients with chronic hepatitis. Further, we show that the weak CTL response is not secondary in infection by mutant viruses lacking these epitopes, and we show that the CTL response did not select for escape mutants in any of these patients. We conclude that an ineffective hepatitis B virus specific CTL response is the primary determinant of viral persistence in chronic hepatitis and that immune selection of viral variants is not a common event in the majority of patients.

References

Dec 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·A BertolettiF V Chisari
Dec 1, 1991·The Journal of Clinical Investigation·T WakitaT Morishima
Jan 1, 1994·The Journal of Clinical Investigation·T I MichalakF V Chisari

❮ Previous
Next ❯

Citations

Jan 13, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T MaruyamaD R Milich
May 29, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·L StuyverF Lunel
Mar 1, 2008·Hepatology International·William S MasonAllison R Jilbert
Sep 29, 2007·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Heng-Gui LiuFu-Sheng Wang
Jun 25, 2003·Journal of Hepatology·Antonio Bertoletti, Nikolai V Naoumov
Mar 2, 2005·Nature Reviews. Immunology·Barbara Rehermann, Michelina Nascimbeni
Jan 22, 2010·Journal of Virology·Hurng-Yi WangDing-Shinn Chen
Jul 15, 2005·Journal of Virology·Stefan F Wieland, Francis V Chisari
Nov 28, 2007·Annual Review of Pathology·Luca G Guidotti, Francis V Chisari
Dec 23, 2011·Gastroenterology Research and Practice·Yasuteru KondoTooru Shimosegawa
Apr 1, 1997·The Journal of Clinical Investigation·F V Chisari
Jun 1, 2005·BMC Microbiology·Benjamin M Chain, Richard Myers
Apr 1, 2009·Clinical Journal of Gastroenterology·Yasuteru KondoTooru Shimosegawa
May 24, 2011·International Journal of Pharmaceutics·Asa SchiöttNikolai Kirkby
Jul 20, 2010·Clinics in Liver Disease·Kyong-Mi Chang
Feb 28, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Helenie KefalakesJoerg Timm
Nov 6, 2007·Clinics in Liver Disease·John M Vierling
Apr 14, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·R D YenR C Dickson
Oct 19, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Pothakamuri Venkata SuneethaHeiner Wedemeyer
Jun 19, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jeremie MartinetCaroline Aspord
Dec 18, 2004·Human Immunology·Yasunobu FukudaTomohiro Kato
Sep 1, 1996·Baillière's Clinical Gastroenterology·B Rehermann
Mar 15, 2006·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Yin HuangCheng Zhou
Jul 18, 2015·Current Opinion in Immunology·Luca G GuidottiFrancis V Chisari
Apr 17, 2016·Journal of Hepatology·Antonio Bertoletti, Carlo Ferrari
Apr 25, 2007·Virology·Chiara De MaddalenaGianguglielmo Zehender
Oct 16, 2016·Clinics in Liver Disease·Bertram Bengsch, Kyong-Mi Chang
Mar 7, 2017·Clinical Pharmacology in Drug Development·Norah J Shire
Sep 6, 2000·Journal of Viral Hepatitis·M K Maini, A Bertoletti
Jun 28, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Antonio Bertoletti, Carlo Ferrari
May 11, 2002·Journal of Cellular and Molecular Medicine·C Kreutz
Oct 14, 2014·World Journal of Gastroenterology : WJG·Chan Ran YouSeung Kew Yoon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.